clavulanic acid has been researched along with Airflow Obstruction, Chronic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Herath, SC; Maisey, S; Normansell, R; Poole, P | 1 |
Cots, JM; Llor, C; Miravitlles, M; Molina, J; Naberan, K | 1 |
Shmelev, EI | 1 |
Dimopoulos, G; Falagas, ME; Korbila, IP; Manta, K; Siempos, II | 1 |
3 review(s) available for clavulanic acid and Airflow Obstruction, Chronic
Article | Year |
---|---|
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Disease Progression; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Roxithromycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
[Respiratory fluoroquinolones in the treatment of exacerbations of chronic obstructive lung disease].
Topics: Administration, Oral; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Injections, Intravenous; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Risk Factors; Time Factors | 2004 |
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Bronchitis; Bronchitis, Chronic; Clavulanic Acid; Clinical Trials as Topic; Humans; Macrolides; Odds Ratio; Pulmonary Disease, Chronic Obstructive; Quinolones; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Treatment Outcome | 2007 |
1 other study(ies) available for clavulanic acid and Airflow Obstruction, Chronic
Article | Year |
---|---|
Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clarithromycin; Clavulanic Acid; Cost of Illness; Cost-Benefit Analysis; Data Collection; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome | 2004 |